Symbol:
Slc16a12
Name:
solute carrier family 16, member 12
RGD ID:
1311468
Description:
Enables creatine transmembrane transporter activity. Involved in creatine transmembrane transport and creatinine metabolic process. Located in basolateral plasma membrane. Human ortholog(s) of this gene implicated in cataract 47. Orthologous to human SLC16A12 (solute carrier family 16 member 12); INTERACTS WITH (+)-schisandrin B; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
LOC309525; MCT 12; monocarboxylate transporter 12; RGD1311468; similar to expressed sequence AW210596; solute carrier family 16 (monocarboxylic acid transporters), member 12; solute carrier family 16, member 12 (monocarboxylic acid transporter 12)
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
SLC16A12 (solute carrier family 16 member 12)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Slc16a12 (solute carrier family 16 (monocarboxylic acid transporters), member 12)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Slc16a12 (solute carrier family 16 member 12)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
SLC16A12 (solute carrier family 16 member 12)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
SLC16A12 (solute carrier family 16 member 12)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Slc16a12 (solute carrier family 16 member 12)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
SLC16A12 (solute carrier family 16 member 12)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
SLC16A12 (solute carrier family 16 member 12)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Slc16a12 (solute carrier family 16 member 12)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
HNRNPA3 (heterogeneous nuclear ribonucleoprotein A3)
HGNC
OMA
Alliance orthologs 3
Mus musculus (house mouse):
Slc16a12 (solute carrier family 16 (monocarboxylic acid transporters), member 12)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
SLC16A12 (solute carrier family 16 member 12)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
slc16a12a (solute carrier family 16 member 12a)
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER|PhylomeDB)
Danio rerio (zebrafish):
slc16a12b (solute carrier family 16 member 12b)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG11665
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER)
Saccharomyces cerevisiae (baker's yeast):
MCH5
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
ESBP6
Alliance
DIOPT (Ensembl Compara|InParanoid|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
MCH2
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG14196
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER)
Saccharomyces cerevisiae (baker's yeast):
MCH4
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Drosophila melanogaster (fruit fly):
Mct1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA)
Caenorhabditis elegans (roundworm):
mct-6
Alliance
DIOPT (Ensembl Compara|Hieranoid|OMA|OrthoInspector|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG8389
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER|PhylomeDB)
Caenorhabditis elegans (roundworm):
mct-5
Alliance
DIOPT (Ensembl Compara|Hieranoid|OrthoInspector|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG8028
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER)
Drosophila melanogaster (fruit fly):
CG8034
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER)
Drosophila melanogaster (fruit fly):
CG8051
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER)
Drosophila melanogaster (fruit fly):
out
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER)
Drosophila melanogaster (fruit fly):
Sln
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
slc16a12
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Allele / Splice:
Slc16a12Tn(sb-T2/Bart3)2.298Mcwi
Genetic Models:
F344-Slc16a12Tn(sb-T2/Bart3)2.298Mcwi
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 241,597,165 - 241,674,821 (-) NCBI GRCr8 mRatBN7.2 1 232,184,004 - 232,262,170 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 232,185,907 - 232,262,141 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 240,579,603 - 240,608,453 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 247,498,691 - 247,521,337 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 240,336,893 - 240,359,535 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 252,976,071 - 253,054,500 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 252,976,644 - 253,000,760 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 260,197,556 - 260,275,962 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 238,643,040 - 238,665,699 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 238,807,343 - 238,830,600 (-) NCBI Celera 1 229,298,962 - 229,321,612 (-) NCBI Celera Cytogenetic Map 1 q53 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Slc16a12 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC16A12 mRNA] CTD PMID:31150632 Slc16a12 Rat 1,2-dimethylhydrazine decreases expression ISO Slc16a12 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC16A12 mRNA CTD PMID:22206623 Slc16a12 Rat 17beta-estradiol multiple interactions ISO SLC16A12 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC16A12 mRNA CTD PMID:30165855 Slc16a12 Rat 17beta-estradiol decreases expression ISO Slc16a12 (Mus musculus) 6480464 Estradiol results in decreased expression of SLC16A12 mRNA CTD PMID:39298647 Slc16a12 Rat 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of SLC16A12 mRNA CTD PMID:32145629 Slc16a12 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC16A12 mRNA CTD PMID:22298810 Slc16a12 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc16a12 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC16A12 mRNA CTD PMID:33956508 Slc16a12 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc16a12 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC16A12 mRNA CTD PMID:28922406 Slc16a12 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO SLC16A12 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC16A12 mRNA CTD PMID:26159488 Slc16a12 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO SLC16A12 (Homo sapiens) 6480464 Endosulfan inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC16A12 mRNA] CTD PMID:26159488 Slc16a12 Rat 2-methylcholine affects expression ISO SLC16A12 (Homo sapiens) 6480464 beta-methylcholine affects the expression of SLC16A12 mRNA CTD PMID:21179406 Slc16a12 Rat 2-palmitoylglycerol increases expression ISO SLC16A12 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of SLC16A12 mRNA CTD PMID:37199045 Slc16a12 Rat 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Slc16a12 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 Slc16a12 Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SLC16A12 mRNA CTD PMID:28522335 Slc16a12 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SLC16A12 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SLC16A12 mRNA CTD PMID:28628672 Slc16a12 Rat 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of SLC16A12 mRNA CTD PMID:30723492 Slc16a12 Rat 4,4'-sulfonyldiphenol increases expression ISO Slc16a12 (Mus musculus) 6480464 bisphenol S results in increased expression of SLC16A12 mRNA CTD PMID:30951980 Slc16a12 Rat 4,4'-sulfonyldiphenol decreases expression ISO Slc16a12 (Mus musculus) 6480464 bisphenol S results in decreased expression of SLC16A12 mRNA CTD PMID:39298647 Slc16a12 Rat 4-hydroxyphenyl retinamide decreases expression ISO Slc16a12 (Mus musculus) 6480464 Fenretinide results in decreased expression of SLC16A12 mRNA CTD PMID:28973697 Slc16a12 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC16A12 mRNA CTD PMID:31881176 Slc16a12 Rat aflatoxin B1 increases expression ISO Slc16a12 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of SLC16A12 mRNA CTD PMID:19770486 Slc16a12 Rat aflatoxin B1 decreases expression ISO SLC16A12 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of SLC16A12 mRNA CTD PMID:22100608 and PMID:32234424 Slc16a12 Rat aristolochic acid A increases expression ISO SLC16A12 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of SLC16A12 mRNA CTD PMID:33212167 Slc16a12 Rat benzo[a]pyrene increases expression ISO Slc16a12 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLC16A12 mRNA CTD PMID:27195522 Slc16a12 Rat benzo[a]pyrene increases methylation ISO SLC16A12 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC16A12 exon and Benzo(a)pyrene results in increased methylation of SLC16A12 promoter CTD PMID:27901495 Slc16a12 Rat benzo[a]pyrene decreases methylation ISO SLC16A12 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of SLC16A12 3' UTR CTD PMID:27901495 Slc16a12 Rat benzo[a]pyrene affects methylation ISO SLC16A12 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC16A12 5' UTR CTD PMID:27901495 Slc16a12 Rat bilirubin IXalpha decreases expression ISO SLC16A12 (Homo sapiens) 6480464 Bilirubin results in decreased expression of SLC16A12 mRNA CTD PMID:20196124 Slc16a12 Rat bisphenol A decreases expression ISO Slc16a12 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC16A12 mRNA CTD PMID:26063408 Slc16a12 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC16A12 mRNA CTD PMID:32145629 Slc16a12 Rat bisphenol A increases expression ISO SLC16A12 (Homo sapiens) 6480464 bisphenol A results in increased expression of SLC16A12 mRNA CTD PMID:31715268 Slc16a12 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC16A12 gene CTD PMID:28505145 Slc16a12 Rat bisphenol A increases expression ISO Slc16a12 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC16A12 mRNA CTD PMID:25594700 Slc16a12 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC16A12 mRNA CTD PMID:25181051 and PMID:34947998 Slc16a12 Rat bisphenol F multiple interactions ISO SLC16A12 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SLC16A12 mRNA CTD PMID:28628672 Slc16a12 Rat bisphenol F increases expression ISO Slc16a12 (Mus musculus) 6480464 bisphenol F results in increased expression of SLC16A12 mRNA CTD PMID:30951980 Slc16a12 Rat cadmium atom decreases expression ISO SLC16A12 (Homo sapiens) 6480464 Cadmium results in decreased expression of SLC16A12 mRNA CTD PMID:24376830 Slc16a12 Rat cadmium atom multiple interactions ISO SLC16A12 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC16A12 mRNA CTD PMID:35301059 Slc16a12 Rat cadmium dichloride multiple interactions ISO SLC16A12 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC16A12 mRNA CTD PMID:35301059 Slc16a12 Rat carbon nanotube increases expression ISO Slc16a12 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of SLC16A12 mRNA CTD PMID:25620056 Slc16a12 Rat cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of SLC16A12 mRNA CTD PMID:18500788 Slc16a12 Rat CGP 52608 multiple interactions ISO SLC16A12 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC16A12 gene] CTD PMID:28238834 Slc16a12 Rat chloropicrin increases expression ISO SLC16A12 (Homo sapiens) 6480464 chloropicrin results in increased expression of SLC16A12 mRNA CTD PMID:26352163 and PMID:28476498 Slc16a12 Rat chloroprene increases expression ISO Slc16a12 (Mus musculus) 6480464 Chloroprene results in increased expression of SLC16A12 mRNA CTD PMID:23125180 Slc16a12 Rat chlorpyrifos increases expression ISO Slc16a12 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SLC16A12 mRNA CTD PMID:37019170 Slc16a12 Rat chromium(6+) affects expression ISO Slc16a12 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of SLC16A12 mRNA CTD PMID:28472532 Slc16a12 Rat cisplatin increases expression ISO SLC16A12 (Homo sapiens) 6480464 Cisplatin results in increased expression of SLC16A12 mRNA CTD PMID:27392435 Slc16a12 Rat cyproconazole increases expression ISO Slc16a12 (Mus musculus) 6480464 cyproconazole results in increased expression of SLC16A12 mRNA CTD PMID:22334560 Slc16a12 Rat dexamethasone multiple interactions ISO SLC16A12 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SLC16A12 mRNA CTD PMID:28628672 Slc16a12 Rat doxorubicin decreases expression ISO SLC16A12 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SLC16A12 mRNA CTD PMID:29803840 Slc16a12 Rat endosulfan multiple interactions ISO SLC16A12 (Homo sapiens) 6480464 Endosulfan inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC16A12 mRNA] CTD PMID:26159488 Slc16a12 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC16A12 mRNA CTD PMID:29391264 Slc16a12 Rat epoxiconazole increases expression ISO Slc16a12 (Mus musculus) 6480464 epoxiconazole results in increased expression of SLC16A12 mRNA CTD PMID:22334560 Slc16a12 Rat epoxiconazole affects expression ISO Slc16a12 (Mus musculus) 6480464 epoxiconazole affects the expression of SLC16A12 mRNA CTD PMID:35436446 Slc16a12 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC16A12 mRNA CTD PMID:24793618 Slc16a12 Rat fonofos increases methylation ISO SLC16A12 (Homo sapiens) 6480464 Fonofos results in increased methylation of SLC16A12 promoter CTD PMID:22847954 Slc16a12 Rat hydrogen peroxide affects expression ISO SLC16A12 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SLC16A12 mRNA CTD PMID:21179406 Slc16a12 Rat hydroxyurea increases mutagenesis ISO Slc16a12 (Mus musculus) 6480464 Hydroxyurea results in increased mutagenesis of SLC16A12 gene CTD PMID:16868089 Slc16a12 Rat indometacin multiple interactions ISO SLC16A12 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SLC16A12 mRNA CTD PMID:28628672 Slc16a12 Rat inulin multiple interactions ISO Slc16a12 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC16A12 mRNA CTD PMID:36331819 Slc16a12 Rat N-methyl-N-nitrosourea increases mutagenesis ISO Slc16a12 (Mus musculus) 6480464 Methylnitrosourea results in increased mutagenesis of SLC16A12 gene CTD PMID:16868089 Slc16a12 Rat nickel sulfate decreases expression ISO SLC16A12 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of SLC16A12 mRNA CTD PMID:22714537 Slc16a12 Rat O-methyleugenol decreases expression ISO SLC16A12 (Homo sapiens) 6480464 methyleugenol results in decreased expression of SLC16A12 mRNA CTD PMID:32234424 Slc16a12 Rat ozone multiple interactions ISO Slc16a12 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SLC16A12 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC16A12 mRNA CTD PMID:34911549 Slc16a12 Rat paracetamol affects expression ISO Slc16a12 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC16A12 mRNA CTD PMID:17562736 Slc16a12 Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SLC16A12 mRNA CTD PMID:32680482 Slc16a12 Rat parathion increases methylation ISO SLC16A12 (Homo sapiens) 6480464 Parathion results in increased methylation of SLC16A12 promoter CTD PMID:22847954 Slc16a12 Rat perfluorohexanesulfonic acid decreases expression ISO Slc16a12 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of SLC16A12 mRNA CTD PMID:37995155 Slc16a12 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Slc16a12 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC16A12 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SLC16A12 mRNA CTD PMID:36331819 Slc16a12 Rat phenobarbital increases expression ISO Slc16a12 (Mus musculus) 6480464 Phenobarbital results in increased expression of SLC16A12 mRNA CTD PMID:19270015 Slc16a12 Rat phenobarbital affects expression ISO Slc16a12 (Mus musculus) 6480464 Phenobarbital affects the expression of SLC16A12 mRNA CTD PMID:23091169 Slc16a12 Rat potassium dichromate decreases expression ISO Slc16a12 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of SLC16A12 mRNA CTD PMID:23608068 Slc16a12 Rat propiconazole increases expression ISO Slc16a12 (Mus musculus) 6480464 propiconazole results in increased expression of SLC16A12 mRNA CTD PMID:22334560 Slc16a12 Rat resveratrol multiple interactions ISO Slc16a12 (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of SLC16A12 mRNA] CTD PMID:31298478 Slc16a12 Rat resveratrol multiple interactions ISO SLC16A12 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC16A12 mRNA CTD PMID:23557933 Slc16a12 Rat rifampicin increases expression ISO SLC16A12 (Homo sapiens) 6480464 Rifampin results in increased expression of SLC16A12 mRNA CTD PMID:24552687 Slc16a12 Rat rifampicin decreases expression ISO SLC16A12 (Homo sapiens) 6480464 Rifampin results in decreased expression of SLC16A12 mRNA CTD PMID:27199754 Slc16a12 Rat senecionine decreases expression ISO Slc16a12 (Mus musculus) 6480464 senecionine results in decreased expression of SLC16A12 protein CTD PMID:35357534 Slc16a12 Rat silver atom decreases expression ISO Slc16a12 (Mus musculus) 6480464 Silver results in decreased expression of SLC16A12 mRNA CTD PMID:27131904 Slc16a12 Rat silver(0) decreases expression ISO Slc16a12 (Mus musculus) 6480464 Silver results in decreased expression of SLC16A12 mRNA CTD PMID:27131904 Slc16a12 Rat sodium arsenite increases expression ISO SLC16A12 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLC16A12 mRNA CTD PMID:29301061 and PMID:38568856 Slc16a12 Rat sodium arsenite decreases expression ISO Slc16a12 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC16A12 mRNA CTD PMID:37682722 Slc16a12 Rat succimer multiple interactions ISO Slc16a12 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC16A12 mRNA CTD PMID:23086747 Slc16a12 Rat terbufos increases methylation ISO SLC16A12 (Homo sapiens) 6480464 terbufos results in increased methylation of SLC16A12 promoter CTD PMID:22847954 Slc16a12 Rat tetrachloromethane decreases expression ISO Slc16a12 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SLC16A12 mRNA CTD PMID:27339419 Slc16a12 Rat tetrachloromethane affects expression ISO Slc16a12 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of SLC16A12 mRNA CTD PMID:31919559 Slc16a12 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC16A12 mRNA CTD PMID:31150632 Slc16a12 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC16A12 mRNA] CTD PMID:31150632 Slc16a12 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC16A12 mRNA CTD PMID:34492290 Slc16a12 Rat titanium dioxide decreases expression ISO Slc16a12 (Mus musculus) 6480464 titanium dioxide results in decreased expression of SLC16A12 mRNA CTD PMID:29264374 Slc16a12 Rat titanium dioxide decreases methylation ISO Slc16a12 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of SLC16A12 gene CTD PMID:35295148 Slc16a12 Rat titanium dioxide multiple interactions ISO Slc16a12 (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of SLC16A12 mRNA] CTD PMID:31298478 Slc16a12 Rat titanium dioxide increases expression ISO Slc16a12 (Mus musculus) 6480464 titanium dioxide results in increased expression of SLC16A12 mRNA CTD PMID:31298478 Slc16a12 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SLC16A12 mRNA CTD PMID:33387578 Slc16a12 Rat triclosan decreases expression ISO SLC16A12 (Homo sapiens) 6480464 Triclosan results in decreased expression of SLC16A12 mRNA CTD PMID:30510588 Slc16a12 Rat trimellitic anhydride decreases expression ISO Slc16a12 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of SLC16A12 mRNA CTD PMID:19042947 Slc16a12 Rat valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SLC16A12 mRNA CTD PMID:29427782
(+)-schisandrin B (EXP) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (EXP,ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-methylcholine (ISO) 2-palmitoylglycerol (ISO) 3,3',4,4'-tetrachlorobiphenyl (ISO) 3-chloropropane-1,2-diol (EXP) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-diaminodiphenylmethane (EXP) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) acetamide (EXP) aflatoxin B1 (ISO) aristolochic acid A (ISO) benzo[a]pyrene (ISO) bilirubin IXalpha (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) cadmium atom (ISO) cadmium dichloride (ISO) carbon nanotube (ISO) cefaloridine (EXP) CGP 52608 (ISO) chloropicrin (ISO) chloroprene (ISO) chlorpyrifos (ISO) chromium(6+) (ISO) cisplatin (ISO) cyproconazole (ISO) dexamethasone (ISO) doxorubicin (ISO) endosulfan (EXP,ISO) epoxiconazole (ISO) flutamide (EXP) fonofos (ISO) hydrogen peroxide (ISO) hydroxyurea (ISO) indometacin (ISO) inulin (ISO) N-methyl-N-nitrosourea (ISO) nickel sulfate (ISO) O-methyleugenol (ISO) ozone (ISO) paracetamol (ISO) paraquat (EXP) parathion (ISO) perfluorohexanesulfonic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) phenobarbital (ISO) potassium dichromate (ISO) propiconazole (ISO) resveratrol (ISO) rifampicin (ISO) senecionine (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) succimer (ISO) terbufos (ISO) tetrachloromethane (EXP,ISO) thioacetamide (EXP) titanium dioxide (ISO) trichloroethene (EXP) triclosan (ISO) trimellitic anhydride (ISO) valproic acid (EXP)
Slc16a12 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 241,597,165 - 241,674,821 (-) NCBI GRCr8 mRatBN7.2 1 232,184,004 - 232,262,170 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 232,185,907 - 232,262,141 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 240,579,603 - 240,608,453 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 247,498,691 - 247,521,337 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 240,336,893 - 240,359,535 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 252,976,071 - 253,054,500 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 252,976,644 - 253,000,760 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 260,197,556 - 260,275,962 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 238,643,040 - 238,665,699 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 238,807,343 - 238,830,600 (-) NCBI Celera 1 229,298,962 - 229,321,612 (-) NCBI Celera Cytogenetic Map 1 q53 NCBI
SLC16A12 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 10 89,430,299 - 89,556,704 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 10 89,430,299 - 89,556,641 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 10 91,190,056 - 91,295,351 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 10 91,180,036 - 91,285,293 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 10 84,936,860 - 85,042,126 (-) NCBI Celera Cytogenetic Map 10 q23.31 NCBI HuRef 10 84,824,228 - 84,929,593 (-) NCBI HuRef CHM1_1 10 91,472,067 - 91,577,412 (-) NCBI CHM1_1 T2T-CHM13v2.0 10 90,314,133 - 90,419,429 (-) NCBI T2T-CHM13v2.0
Slc16a12 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 19 34,645,801 - 34,725,223 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 19 34,645,803 - 34,724,689 (-) Ensembl GRCm39 Ensembl GRCm38 19 34,668,401 - 34,747,493 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 19 34,668,403 - 34,747,289 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 19 34,742,896 - 34,821,601 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 19 34,734,403 - 34,813,108 (-) NCBI MGSCv36 mm8 Celera 19 35,442,689 - 35,521,028 (-) NCBI Celera Cytogenetic Map 19 C1 NCBI cM Map 19 29.79 NCBI
Slc16a12 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955425 3,509,142 - 3,560,138 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955425 3,474,814 - 3,560,138 (+) NCBI ChiLan1.0 ChiLan1.0
SLC16A12 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 8 101,446,803 - 101,481,472 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 10 101,452,146 - 101,486,786 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 10 86,155,527 - 86,187,917 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 10 89,696,148 - 89,727,585 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 10 89,696,148 - 89,727,585 (-) Ensembl panpan1.1 panPan2
SLC16A12 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 28 4,343,773 - 4,430,653 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 28 4,345,546 - 4,421,234 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 28 4,579,217 - 4,664,998 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 28 4,565,289 - 4,652,174 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 28 4,567,687 - 4,651,465 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 28 4,323,134 - 4,402,863 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 28 4,365,926 - 4,445,342 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 28 4,501,245 - 4,580,912 (-) NCBI UU_Cfam_GSD_1.0
Slc16a12 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024407213 43,114,853 - 43,133,513 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936601 4,747,489 - 4,763,697 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936601 4,685,215 - 4,766,116 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
SLC16A12 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 14 101,273,996 - 101,368,132 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 14 101,273,977 - 101,368,350 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 14 110,262,470 - 110,354,305 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SLC16A12 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 9 82,817,476 - 82,917,004 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 9 82,818,994 - 82,916,837 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666048 43,493,620 - 43,592,283 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Slc16a12 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 54 Count of miRNA genes: 48 Interacting mature miRNAs: 53 Transcripts: ENSRNOT00000030024 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
8693637 Alc29 Alcohol consumption QTL 29 2.7 0.258 drinking behavior trait (VT:0001422) calculated ethanol drink intake rate (CMO:0001615) 1 207987464 234238494 Rat 1578778 Pur4 Proteinuria QTL 4 3.3 0.003 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 1 150700247 252085048 Rat 1354646 Kidm18 Kidney mass QTL 18 5.7 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 151162512 256448636 Rat 1357335 Bw39 Body weight QTL 39 3.3 body mass (VT:0001259) body weight (CMO:0000012) 1 197814409 242814409 Rat 2302375 Bw83 Body weight QTL 83 4.87 0.0002 body mass (VT:0001259) body weight (CMO:0000012) 1 197697768 242697768 Rat 1354652 Kidm20 Kidney mass QTL 20 4.3 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 177227632 256448636 Rat 2293674 Bss39 Bone structure and strength QTL 39 7.1 0.0001 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 1 201554356 246554356 Rat 2302378 Insul11 Insulin level QTL 11 3.25 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 1 144267353 251128347 Rat 61455 Niddm7 Non-insulin dependent diabetes mellitus QTL 7 5.5 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 1 214537555 238757011 Rat 61327 Eae7 Experimental allergic encephalomyelitis QTL 7 5.6 body mass (VT:0001259) change in body weight (CMO:0002045) 1 216255568 260522016 Rat 1600392 Bw123 Body weight QTL 123 0.001 body mass (VT:0001259) body weight (CMO:0000012) 1 223201027 260522016 Rat 7794788 Mcs32 Mammary carcinoma susceptibility QTL 32 2.61 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 1 115540693 238914717 Rat 1578763 Kidm29 Kidney mass QTL 29 3.3 0.0001 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 1 179567751 260522016 Rat 1600395 Niddm69 Non-insulin dependent diabetes mellitus QTL 69 4.14 0.0002 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 1 195804352 257091168 Rat 1354624 Cm35 Cardiac mass QTL35 5.7 heart left ventricle mass (VT:0007031) calculated heart weight (CMO:0000073) 1 177227632 256448636 Rat 1600396 Niddm68 Non-insulin dependent diabetes mellitus QTL 68 4.97 0.0003 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 1600397 Edcs4 Endometrial carcinoma susceptibility QTL 4 2.2 uterus morphology trait (VT:0001120) percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759) 1 206081677 251081677 Rat 1549837 Hcar15 Hepatocarcinoma resistance QTL 15 0.05 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 153136852 260522016 Rat 152025235 Bw194 Body weight QTL 194 4.86 body mass (VT:0001259) 1 123556856 242907031 Rat 1600388 Niddm67 Non-insulin dependent diabetes mellitus QTL 67 5.84 0.000004 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 2293694 Bss38 Bone structure and strength QTL 38 7.05 0.0001 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 1 201554356 246554356 Rat 1578759 Uae30 Urinary albumin excretion QTL 30 3.3 0.003 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 150700247 252085048 Rat 1300108 Rf8 Renal function QTL 8 3.75 renal blood flow trait (VT:2000006) absolute change in renal vascular resistance (CMO:0001900) 1 228581588 259647894 Rat 8655655 Arrd2 Age-related retinal degeneration QTL 2 7.79 retinal layer morphology trait (VT:0003727) percentage of study population developing retinopathy during a period of time (CMO:0002453) 1 183970203 243914901 Rat 734767 Niddm57 Non-insulin dependent diabetes mellitus QTL 57 body mass (VT:0001259) body weight (CMO:0000012) 1 224054293 260122809 Rat 1358898 Bp255 Blood pressure QTL 255 3.6 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 191019702 246062233 Rat 631215 Stl8 Serum triglyceride level QTL 8 9.27 0.0001 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 1 225126575 260522016 Rat 631843 Bw116 Body weight QTL 116 4.1 0.016 abdominal adipose amount (VT:1000220) abdominal fat pad weight (CMO:0000088) 1 224054293 260122809 Rat 2300175 Bmd40 Bone mineral density QTL 40 15.4 0.0001 femur mineral mass (VT:0010011) bone mineral density (CMO:0001226) 1 201554356 246554356 Rat 731175 Uae20 Urinary albumin excretion QTL 20 3.5 0.0018 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 221264111 259647894 Rat 1354661 Bw33 Body weight QTL 33 5.2 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 724538 Kidm1 Kidney mass QTL 1 3.2 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 213707201 252085212 Rat 2293655 Bss36 Bone structure and strength QTL 36 10.66 0.0001 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 1 201554356 246554356 Rat 1298084 Thym4 Thymus enlargement QTL 4 10.68 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 1 197814409 242814409 Rat 724531 Uae5 Urinary albumin excretion QTL 5 4 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 1 150700142 252085212 Rat 8552891 Epfw5 Epididymal fat weight QTL 5 4.4 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 1 193113876 238113876 Rat 734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 body mass (VT:0001259) body weight (CMO:0000012) 1 224569538 260122809 Rat 734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 body mass (VT:0001259) body weight (CMO:0000012) 1 213843987 258843987 Rat 1358890 Bp259 Blood pressure QTL 259 3.06 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 210702053 260522016 Rat 724533 Rf51 Renal function QTL 51 5.3 0.0002 kidney plasma flow trait (VT:0005524) renal plasma flow (CMO:0001914) 1 218753816 256448513 Rat 1354580 Scort1 Serum corticosterone level QTL 1 3.4 blood corticosterone amount (VT:0005345) blood corticosterone level (CMO:0001172) 1 156677124 256448636 Rat 1358292 Cm37 Cardiac mass QTL 37 6.2 8e-07 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 1 196248093 241248093 Rat 61376 Bp42 Blood pressure QTL 42 23.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 197814409 242814409 Rat 634313 Niddm43 Non-insulin dependent diabetes mellitus QTL 43 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 199050459 259647894 Rat 1549910 Bw54 Body weight QTL 54 0.05 body mass (VT:0001259) body weight (CMO:0000012) 1 214647894 259647894 Rat 70211 Niddm24 Non-insulin dependent diabetes mellitus QTL 24 3.79 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 214647894 259647894 Rat 1357399 Bw45 Body weight QTL 45 3.05 body mass (VT:0001259) body mass index (BMI) (CMO:0000105) 1 206329708 251329708 Rat 724552 Glom2 Glomerulus QTL 2 3.3 0.0001 kidney glomerulus morphology trait (VT:0005325) count of superficial glomeruli directly contacting the kidney surface (CMO:0001001) 1 222363780 260522016 Rat 2316896 Gluco57 Glucose level QTL 57 7.2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 228985440 245907899 Rat 1357404 Bw42 Body weight QTL 42 4.49 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 1 206329708 251329708 Rat 10053715 Scort24 Serum corticosterone level QTL 24 2.13 0.0088 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 1 221414816 260522016 Rat 7421630 Bp362 Blood pressure QTL 362 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 118608292 241799120 Rat 1358916 Kidm22 Kidney mass QTL 22 3.32 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 1 210702053 240947965 Rat 634321 Hc1 Hypercalciuria QTL 1 2.91 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 1 178810256 240830002 Rat 61400 Niddm1 Non-insulin dependent diabetes mellitus QTL 1 11 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 218753689 245907899 Rat 10059587 Bw173 Body weight QTL 173 3.23 0.025 body mass (VT:0001259) body weight (CMO:0000012) 1 202069611 247069611 Rat 2292216 Bw80 Body weight QTL 80 3.23 0.0019 body mass (VT:0001259) body weight (CMO:0000012) 1 213533809 243914901 Rat 2292220 Bp306 Blood pressure QTL 306 3.47 0.00087 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 164310393 243914901 Rat 10059590 Kidm44 Kidney mass QTL 44 3.42 0.025 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 1 191033875 236033875 Rat 1641926 Teswt2 Testicular weight QTL 2 2.82 testis mass (VT:1000644) both testes wet weight (CMO:0000175) 1 197697768 238755659 Rat 631658 Cm7 Cardiac mass QTL 7 5.32 0.0001 aorta mass (VT:0002845) aorta weight (CMO:0000076) 1 196248093 241248093 Rat 1354610 Bw34 Body weight QTL 34 4.1 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 2293700 Bmd27 Bone mineral density QTL 27 6.6 0.0001 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 1 224054293 243747962 Rat 2293701 Bmd34 Bone mineral density QTL 34 8.3 0.0001 femur strength trait (VT:0010010) femoral neck ultimate force (CMO:0001703) 1 224054293 243747962 Rat 7387289 Uae45 Urinary albumin excretion QTL 45 2.86 0.0021 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 223262787 260522016 Rat 8655855 Arrd3 Age-related retinal degeneration QTL 3 3.07 lens clarity trait (VT:0001304) cataract incidence/prevalence measurement (CMO:0001585) 1 183970203 243914901 Rat 1600374 Mcs17 Mammary carcinoma susceptibility QTL 17 3 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 1 197670404 242670404 Rat 1581544 Rf52 Renal function QTL 52 0.05 urine total protein amount (VT:0000032) urine protein excretion rate to body weight ratio (CMO:0001099) 1 232156370 259647894 Rat 1600363 Hc6 Hypercalciuria QTL 6 2.7 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 1 203995416 244113296 Rat 738032 Hcas5 Hepatocarcinoma susceptibility QTL 5 3.12 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 176426412 257976495 Rat 1358191 Ept10 Estrogen-induced pituitary tumorigenesis QTL 10 3.8 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 1 192825253 243914732 Rat 2302040 Pia35 Pristane induced arthritis QTL 35 3.8 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 1 216255568 260522016 Rat 7394701 Uae46 Urinary albumin excretion QTL 46 3.6 0.0056 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 201554356 246554356 Rat 1598821 Rf55 Renal function QTL 55 6.3 renal blood flow trait (VT:2000006) ratio of change in renal blood flow to change in renal perfusion pressure (CMO:0001239) 1 218748008 257976495 Rat
RH139695
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 232,261,919 - 232,262,109 (+) MAPPER mRatBN7.2 Rnor_6.0 1 253,054,145 - 253,054,334 NCBI Rnor6.0 Rnor_5.0 1 260,275,712 - 260,275,901 UniSTS Rnor5.0 RGSC_v3.4 1 238,718,730 - 238,718,919 UniSTS RGSC3.4 Celera 1 229,374,607 - 229,374,796 UniSTS RH 3.4 Map 4 511.02 UniSTS Cytogenetic Map 1 q52 UniSTS
This gene Slc16a12 is modified in the following models/strains:
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000030024 ⟹ ENSRNOP00000038838
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 232,185,907 - 232,262,141 (-) Ensembl Rnor_6.0 Ensembl 1 252,976,644 - 253,000,760 (-) Ensembl
RefSeq Acc Id:
NM_001191637 ⟹ NP_001178566
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 241,599,066 - 241,621,716 (-) NCBI mRatBN7.2 1 232,185,907 - 232,208,555 (-) NCBI Rnor_6.0 1 252,977,974 - 253,000,624 (-) NCBI Rnor_5.0 1 260,197,556 - 260,275,962 (-) NCBI Celera 1 229,298,962 - 229,321,612 (-) NCBI
Sequence:
ATGACGAAGATAACTAGAGTTGGTTCCGCATCCCCTCCAGATGGAGGCTGGGGATGGATGATTGTGGCCGGCTGCTTTCTTGTTACCATCTGCACCCGGGCAGTCACCAGGTGTATCTCCATATTTTT TGTGGAGTTTCAGACGTACTTTGCTCAGGATTATTCCCAAACAGCATGGATCCATTCCATTGTAGACTGCATGACAATGCTCTGTGCTCCGCTTGGGAGTGTTGTCAGTAACCAATTATCCTGTCAAG CGGGGATCATGCTGGGTGGCTTGCTGGCATCTACTGGTCTCATCCTGGGCTCATTTGCCACCAGTTTGAAGCACCTCTACCTCAGTCTGGGAGTTCTCACAGGTCTTGGATTTGCACTTTGTTACTCC CCAGCAATTGCCATGGTGGGCAAGTACTTCAGCAGGCGGAAAGCCTTCGCTTACGGGATTGCCATGTCAGGCAGTGGCATTGGTACCTTCATCCTGGCCCCTGTGGTTCAGCTCCTCATTGAACAGTT CTCCTGGCGAGGAGCACTGCTCATTCTTGGTGGGTTCGTTCTGAATCTCTGCGTCTGCGGCGCGCTGATGCGTCCAATTACCCTTAAAGAGGACCCGTCAGGCCCAGAGAAGAGTCACGACCGTGACG CTCAGAGAGAAGACTGTAAGCAGGCATCTCCCTATTCACCTTTGACCAAAGAATGGACAGAGACCCGTCTTTGCTGCTCTTTGCAGCAAGGATACGGCTTTTTACTGATGTCAGACTTCGTCGTGCTG GCTGTCTCTGTTCTGTTCATGGCCTACGGCTGCAGCCCTCTCTTTGTGTACCTGGTGCCTTATGCTTTGAGTGTCGGAGTGAGTCACCATCAAGCTGCTTTCCTCATGTCCATCCTCGGAGTGATTGA TATTGTCGGCAACATCACGTTTGGCTGGCTAACTGACAGAAGGTGTCTGAAGAATTACCGATATGTTTGCTACCTCTTTGCTGTGGCACTAGATGGGCTGTGCTATCTGTGTCTCCCAATGCTTCAAA GCTTCCCCCTTCTTGTGCCTTTCTCTTGTACCTTTGGCTACTTCGACGGAGCCTACGTTACCTTGATCCCAGTAGTGACTGCAGAGATAGTAGGGACCACCTCTTTGTCATCAGCACTTGGCGTGGTC TACTTCCTCCATGCAGTGCCATACTTGGTGAGCCCACCCATTGCAGGATGGCTGGTGGACACGACGGGCAGCTATACTGCAGCCTTCCTTCTTTGTGGATTTGCCATGATATTTAGTTCCATCCTGCT TGGCTTTGCCAAAATTGCAAAAAGAATGAAAAGAACACAGGTGCCCTTCCTGGTCAAAGACTCAGATCCCAAGCTGCATCTGTGGACCAATGGATCAGTGGCCTACTCTATAGCGAAGGAGTTAGATC AGAAAGATGAGGAATCCCTGGCTAAAGCTAGGACTGGTTGCAATCTCACATGACCTGTGTGGCCTTGTCCTGGGAATCTGCAAGGCTGGTGGATACCAGGCCACCAGGTTGTTCACAGTCTGGAAATA TTTTATTTTGACAGAGTATCACCTCCCAAGTAAATTATTAATACTGTTTTGTTAACATATTTATATGGGGACAATAATGAGCAACAAAGAAATCTGGAGTTAGCCTGGAGTTTTCTCATTCAGGATTT GTACTCACTACAAACTTAGCTCTGGGAGAAGGGCAGGACACAGTTGACAGGGTCAGTTGTATTTCAGGACAACTCTAAGCAGAGGCCACTGTGAAGAGTTTTCATAAAATCTGCCCCACCCCCTCATT CTGAACAGAAGCAGTGGTGGTTGTGCTGGCAGTGGGGATGCAGAGGTGACTTGAGAACAGAGCGCCTCAATGTTTAGAGTGGCA
hide sequence
RefSeq Acc Id:
XM_017589300 ⟹ XP_017444789
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 241,597,165 - 241,674,078 (-) NCBI mRatBN7.2 1 232,186,279 - 232,262,170 (-) NCBI Rnor_6.0 1 252,978,244 - 253,054,500 (-) NCBI
Sequence:
GGGGATGGCTAGCTAGGAAACTGCAGGACAGATGCCTCCTGGAGGGCGGGGCAAACACCATTTACCCTCCACTGTTAAGGAACCTGGCACCCCATTTTTTCTTCAGCAGGAGCAAACTTTGTTTTTAT TTTATTGAGAAACTGAGACCAAGTGAACTGTTTAAAGTCATAGAGTTTGCGAGCGAGTTGAACTCAAGTCCTTAGGACTGATTGATGTGTGCAGTGGTCTGACCAGGGTCCTGGTCCTTGCCAGATGC CGGTGCAGGAGACTTTGAACAGCTTCTACTCTCTGACCATTCAGGGACATAGTCTTCTGGAGAACACCCAGGCACTCCTTTAGTGTAGGTCCCAGGCACACAGGGCTGTTCCAGAGAGAGCCCTGCAA GTCCCTAGTGGGCTGGCTCGTGACTCGGCGGGCCGGCCGGGCCGGAGCATTACATAACCTGGAGGCGCCCCTCCTCCGTGGCCGAGCCCCCAGCGCAGAGCGGATCCGGGGACAAGGCCAGTCTGGCA GCAGGGCAGAGTCACCCTCGGGGCTGGCGTCACTGAGAGCCTTGGTTCTCCGGGGCGGGGCGGTGGGATCTCCTCAGTGACAGTGTCCGGCGGGCTCTGCCTGTGGCCCCGGCCCCTACGGCGCCTCC GCCCCGTGCGCACCCCGCCCCTCGGCCGGACCGGACTCCAGGGGCCGTGGGAAGGGGCCGCCGTGCAGGGGGCATGTGGGCTCACCGTCGCCAGCTCTGCAGCTGTCCCCGCGAGTGCAAGCTGATGA TTCAGCGTTCCGAACCACTCGCTCGCGTTTTGTCTGGACGCTGGTTCGTTCTTCCCAGCTTTGCTGAGAGCTATGTGGGCAATTCCAGCGGCTCTGCTGACCTAGTCCAGAAGGAAAAATCTTCAGGC TTGCCAAGTTCAGGAAGACCCCGTGGCTACAGATGGGCAGTAATCCCTGTGCCAGGTAGCATCCTGAACCAACTTTGAGGATCAACAGGAAGTTGCTGGGTAGCAACCACTGAGGATCCTAACTTACT GCTGCAGTGACCTGGAAAGAGAAGAAAACCAAAATTGCAACCATGACGAAGATAACTAGAGTTGGTTCCGCATCCCCTCCAGATGGAGGCTGGGGATGGATGATTGTGGCCGGCTGCTTTCTTGTTAC CATCTGCACCCGGGCAGTCACCAGGTGTATCTCCATATTTTTTGTGGAGTTTCAGACGTACTTTGCTCAGGATTATTCCCAAACAGCATGGATCCATTCCATTGTAGACTGCATGACAATGCTCTGTG CTCCGCTTGGGAGTGTTGTCAGTAACCAATTATCCTGTCAAGCGGGGATCATGCTGGGTGGCTTGCTGGCATCTACTGGTCTCATCCTGGGCTCATTTGCCACCAGTTTGAAGCACCTCTACCTCAGT CTGGGAGTTCTCACAGGTCTTGGATTTGCACTTTGTTACTCCCCAGCAATTGCCATGGTGGGCAAGTACTTCAGCAGGCGGAAAGCCTTCGCTTACGGGATTGCCATGTCAGGCAGTGGCATTGGTAC CTTCATCCTGGCCCCTGTGGTTCAGCTCCTCATTGAACAGTTCTCCTGGCGAGGAGCACTGCTCATTCTTGGTGGGTTCGTTCTGAATCTCTGCGTCTGCGGCGCGCTGATGCGTCCAATTACCCTTA AAGAGGACCCGTCAGGCCCAGAGAAGAGTCACGACCGTGACGCTCAGAGAGAAGACTGTAAGCAGGCATCTCCCTATTCACCTTTGACCAAAGAATGGACAGAGACCCGTCTTTGCTGCTCTTTGCAG CAAGGATACGGCTTTTTACTGATGTCAGACTTCGTCGTGCTGGCTGTCTCTGTTCTGTTCATGGCCTACGGCTGCAGCCCTCTCTTTGTGTACCTGGTGCCTTATGCTTTGAGTGTCGGAGTGAGTCA CCATCAAGCTGCTTTCCTCATGTCCATCCTCGGAGTGATTGATATTGTCGGCAACATCACGTTTGGCTGGCTAACTGACAGAAGGTGTCTGAAGAATTACCGATATGTTTGCTACCTCTTTGCTGTGG CACTAGATGGGCTGTGCTATCTGTGTCTCCCAATGCTTCAAAGCTTCCCCCTTCTTGTGCCTTTCTCTTGTACCTTTGGCTACTTCGACGGAGCCTACGTTACCTTGATCCCAGTAGTGACTGCAGAG ATAGTAGGGACCACCTCTTTGTCATCAGCACTTGGCGTGGTCTACTTCCTCCATGCAGTGCCATACTTGGTGAGCCCACCCATTGCAGGATGGCTGGTGGACACGACGGGCAGCTATACTGCAGCCTT CCTTCTTTGTGGATTTGCCATGATATTTAGTTCCATCCTGCTTGGCTTTGCCAAAATTGCAAAAAGAATGAAAAGAACACAGGTGCCCTTCCTGGTCAAAGACTCAGATCCCAAGCTGCATCTGTGGA CCAATGGATCAGTGGCCTACTCTATAGCGAAGGAGTTAGATCAGAAAGATGAGGAATCCCTGGCTAAAGCTAGGACTGGTTGCAATCTCACATGACCTGTGTGGCCTTGTCCTGGGAATCTGCAAGGC TGGTGGATACCAGGCCACCAGGTTGTTCACAGTCTGGAAATATTTTATTTTGACAGAGTATCACCTCCCAAGTAAATTATTAATACTGTTTTGTTAACATATTTATATGGGG
hide sequence
RefSeq Acc Id:
XM_017589301 ⟹ XP_017444790
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 241,597,165 - 241,674,821 (-) NCBI mRatBN7.2 1 232,184,004 - 232,262,170 (-) NCBI Rnor_6.0 1 252,978,244 - 253,054,500 (-) NCBI
Sequence:
GGGGATGGCTAGCTAGGAAACTGCAGGACAGATGCCTCCTGGAGGGCGGGGCAAACACCATTTACCCTCCACTGTTAAGGAACCTGGCACCCCATTTTTTCTTCAGCAGGAGCAAACTTTGTTTTTAT TTTATTGAGAAACTGAGACCAAGTGAACTGTTTAAAGTCATAGAGTTTGCGAGCGAGTTGAACTCAAGTCCTTAGGACTGATTGATGTGTGCAGTGGTCTGACCAGGGTCCTGGTCCTTGCCAGATGC CGGTGCAGGAGACTTTGAACAGCTTCTACTCTCTGACCATTCAGGGACATAGTCTTCTGGAGAACACCCAGGCACTCCTTTAGTGTAGGTCCCAGGCACACAGGGCTGTTCCAGAGAGAGCCCTGCAA GTCCCTAGTGGGCTGGCTCGTGACTCGGCGGGCCGGCCGGGCCGGAGCATTACATAACCTGGAGGCGCCCCTCCTCCGTGGCCGAGCCCCCAGCGCAGAGCGGATCCGGGGACAAGGCCAGTCTGGCA GCAGGGCAGAGTCACCCTCGGGGCTGGCGTCACTGAGAGCCTTGGTTCTCCGGGGCGGGGCGGTGGGATCTCCTCAGTGACAGTGTCCGGCGGGCTCTGCCTGTGGCCCCGGCCCCTACGGCGCCTCC GCCCCGTGCGCACCCCGCCCCTCGGCCGGACCGGACTCCAGGGGCCGTGGGAAGGGGCCGCCGTGCAGGGGGCATGTGGGCTCACCGTCGCCAGCTCTGCAGCTGTCCCCGCGAGATGGGCAGTAATC CCTGTGCCAGGTAGCATCCTGAACCAACTTTGAGGATCAACAGGAAGTTGCTGGGTAGCAACCACTGAGGATCCTAACTTACTGCTGCAGTGACCTGGAAAGAGAAGAAAACCAAAATTGCAACCATG ACGAAGATAACTAGAGTTGGTTCCGCATCCCCTCCAGATGGAGGCTGGGGATGGATGATTGTGGCCGGCTGCTTTCTTGTTACCATCTGCACCCGGGCAGTCACCAGGTGTATCTCCATATTTTTTGT GGAGTTTCAGACGTACTTTGCTCAGGATTATTCCCAAACAGCATGGATCCATTCCATTGTAGACTGCATGACAATGCTCTGTGCTCCGCTTGGGAGTGTTGTCAGTAACCAATTATCCTGTCAAGCGG GGATCATGCTGGGTGGCTTGCTGGCATCTACTGGTCTCATCCTGGGCTCATTTGCCACCAGTTTGAAGCACCTCTACCTCAGTCTGGGAGTTCTCACAGGTCTTGGATTTGCACTTTGTTACTCCCCA GCAATTGCCATGGTGGGCAAGTACTTCAGCAGGCGGAAAGCCTTCGCTTACGGGATTGCCATGTCAGGCAGTGGCATTGGTACCTTCATCCTGGCCCCTGTGGTTCAGCTCCTCATTGAACAGTTCTC CTGGCGAGGAGCACTGCTCATTCTTGGTGGGTTCGTTCTGAATCTCTGCGTCTGCGGCGCGCTGATGCGTCCAATTACCCTTAAAGAGGACCCGTCAGGCCCAGAGAAGAGTCACGACCGTGACGCTC AGAGAGAAGACTGTAAGCAGGCATCTCCCTATTCACCTTTGACCAAAGAATGGACAGAGACCCGTCTTTGCTGCTCTTTGCAGCAAGGATACGGCTTTTTACTGATGTCAGACTTCGTCGTGCTGGCT GTCTCTGTTCTGTTCATGGCCTACGGCTGCAGCCCTCTCTTTGTGTACCTGGTGCCTTATGCTTTGAGTGTCGGAGTGAGTCACCATCAAGCTGCTTTCCTCATGTCCATCCTCGGAGTGATTGATAT TGTCGGCAACATCACGTTTGGCTGGCTAACTGACAGAAGGTGTCTGAAGAATTACCGATATGTTTGCTACCTCTTTGCTGTGGCACTAGATGGGCTGTGCTATCTGTGTCTCCCAATGCTTCAAAGCT TCCCCCTTCTTGTGCCTTTCTCTTGTACCTTTGGCTACTTCGACGGAGCCTACGTTACCTTGATCCCAGTAGTGACTGCAGAGATAGTAGGGACCACCTCTTTGTCATCAGCACTTGGCGTGGTCTAC TTCCTCCATGCAGTGCCATACTTGGTGAGCCCACCCATTGCAGGATGGCTGGTGGACACGACGGGCAGCTATACTGCAGCCTTCCTTCTTTGTGGATTTGCCATGATATTTAGTTCCATCCTGCTTGG CTTTGCCAAAATTGCAAAAAGAATGAAAAGAACACAGGTGCCCTTCCTGGTCAAAGACTCAGATCCCAAGCTGCATCTGTGGACCAATGGATCAGTGGCCTACTCTATAGCGAAGGAGTTAGATCAGA AAGATGAGGAATCCCTGGCTAAAGCTAGGACTGGTTGCAATCTCACATGACCTGTGTGGCCTTGTCCTGGGAATCTGCAAGGCTGGTGGATACCAGGCCACCAGGTTGTTCACAGTCTGGAAATATTT TATTTTGACAGAGTATCACCTCCCAAGTAAATTATTAATACTGTTTTGTTAACATATTTATATGGGG
hide sequence
RefSeq Acc Id:
NP_001178566 ⟸ NM_001191637
- UniProtKB:
D4A734 (UniProtKB/TrEMBL)
- Sequence:
MTKITRVGSASPPDGGWGWMIVAGCFLVTICTRAVTRCISIFFVEFQTYFAQDYSQTAWIHSIVDCMTMLCAPLGSVVSNQLSCQAGIMLGGLLASTGLILGSFATSLKHLYLSLGVLTGLGFALCYS PAIAMVGKYFSRRKAFAYGIAMSGSGIGTFILAPVVQLLIEQFSWRGALLILGGFVLNLCVCGALMRPITLKEDPSGPEKSHDRDAQREDCKQASPYSPLTKEWTETRLCCSLQQGYGFLLMSDFVVL AVSVLFMAYGCSPLFVYLVPYALSVGVSHHQAAFLMSILGVIDIVGNITFGWLTDRRCLKNYRYVCYLFAVALDGLCYLCLPMLQSFPLLVPFSCTFGYFDGAYVTLIPVVTAEIVGTTSLSSALGVV YFLHAVPYLVSPPIAGWLVDTTGSYTAAFLLCGFAMIFSSILLGFAKIAKRMKRTQVPFLVKDSDPKLHLWTNGSVAYSIAKELDQKDEESLAKARTGCNLT
hide sequence
RefSeq Acc Id:
XP_017444790 ⟸ XM_017589301
- Peptide Label:
isoform X1
- UniProtKB:
D4A734 (UniProtKB/TrEMBL)
- Sequence:
MTKITRVGSASPPDGGWGWMIVAGCFLVTICTRAVTRCISIFFVEFQTYFAQDYSQTAWIHSIVDCMTMLCAPLGSVVSNQLSCQAGIMLGGLLASTGLILGSFATSLKHLYLSLGVLTGLGFALCYS PAIAMVGKYFSRRKAFAYGIAMSGSGIGTFILAPVVQLLIEQFSWRGALLILGGFVLNLCVCGALMRPITLKEDPSGPEKSHDRDAQREDCKQASPYSPLTKEWTETRLCCSLQQGYGFLLMSDFVVL AVSVLFMAYGCSPLFVYLVPYALSVGVSHHQAAFLMSILGVIDIVGNITFGWLTDRRCLKNYRYVCYLFAVALDGLCYLCLPMLQSFPLLVPFSCTFGYFDGAYVTLIPVVTAEIVGTTSLSSALGVV YFLHAVPYLVSPPIAGWLVDTTGSYTAAFLLCGFAMIFSSILLGFAKIAKRMKRTQVPFLVKDSDPKLHLWTNGSVAYSIAKELDQKDEESLAKARTGCNLT
hide sequence
RefSeq Acc Id:
XP_017444789 ⟸ XM_017589300
- Peptide Label:
isoform X1
- UniProtKB:
D4A734 (UniProtKB/TrEMBL)
- Sequence:
MTKITRVGSASPPDGGWGWMIVAGCFLVTICTRAVTRCISIFFVEFQTYFAQDYSQTAWIHSIVDCMTMLCAPLGSVVSNQLSCQAGIMLGGLLASTGLILGSFATSLKHLYLSLGVLTGLGFALCYS PAIAMVGKYFSRRKAFAYGIAMSGSGIGTFILAPVVQLLIEQFSWRGALLILGGFVLNLCVCGALMRPITLKEDPSGPEKSHDRDAQREDCKQASPYSPLTKEWTETRLCCSLQQGYGFLLMSDFVVL AVSVLFMAYGCSPLFVYLVPYALSVGVSHHQAAFLMSILGVIDIVGNITFGWLTDRRCLKNYRYVCYLFAVALDGLCYLCLPMLQSFPLLVPFSCTFGYFDGAYVTLIPVVTAEIVGTTSLSSALGVV YFLHAVPYLVSPPIAGWLVDTTGSYTAAFLLCGFAMIFSSILLGFAKIAKRMKRTQVPFLVKDSDPKLHLWTNGSVAYSIAKELDQKDEESLAKARTGCNLT
hide sequence
Ensembl Acc Id:
ENSRNOP00000038838 ⟸ ENSRNOT00000030024
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-09-19
Slc16a12
solute carrier family 16, member 12 (monocarboxylic acid transporter 12)
Slc16a12
solute carrier family 16 (monocarboxylic acid transporters), member 12
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
Slc16a12
solute carrier family 16 (monocarboxylic acid transporters), member 12
Slc16a12_predicted
solute carrier family 16 (monocarboxylic acid transporters), member 12 (predicted)
'predicted' is removed
2292626
APPROVED
2006-03-30
Slc16a12_predicted
solute carrier family 16 (monocarboxylic acid transporters), member 12 (predicted)
RGD1311468_predicted
similar to expressed sequence AW210596 (predicted)
Symbol and Name updated
1299863
APPROVED
2005-01-20
RGD1311468_predicted
similar to expressed sequence AW210596 (predicted)
LOC309525_predicted
Symbol and Name status set to approved
1331353
APPROVED
2005-01-12
LOC309525_predicted
similar to expressed sequence AW210596 (predicted)
Symbol and Name status set to provisional
70820
PROVISIONAL